Anhui Hongyu Wuzhou Medical Instrument Co., Ltd. is located at No. 2, Guanyin Road, Economic Development Zone, the Taihu Lake County, Anqing City. The company is a high-tech enterprise specializing in the research, development, production and sales of disposable sterile medical instruments, and also a key training unit with specialized and new "Little Giant" policy support as assessed by the Ministry of Industry and Information Technology. The company was listed on the Shenzhen Stock Exchange Growth Enterprise Board in July 2022 (stock abbreviation: Wuzhou Medical Stock Code: 301234).
It is 200 kilometers away from the provincial capital Hefei City by land, 100 kilometers away from Anqing City by land, close to the entrance of Shanghai Chengdu Expressway, 2 kilometers away from Hejiu Railway the Taihu Lake Station, 105 National Highway Bus Station, and 9 kilometers away from the "High speed Railway the Taihu Lake South Station".
Hongyu Wuzhou Company was established in April 2011, with over 900 employees and over 1000 advanced automated production equipment at home and abroad. It has obtained more than 70 inventions and creations, and has built a 100000 level purification workshop that meets GMP standards of 45000 square meters, equipped with professional testing instruments and a complete quality inspection center. After more than ten years of development, the company has fully mastered the advanced technology of producing disposable sterile medical devices. Its leading products include three series: disposable syringes, infusion (blood) devices, and puncture needles. All products have passed ISO13485 quality management system certification, EU CE certification, and FDA quality management system certification. Each series of products is exported to more than 80 countries and regions overseas, and currently has achieved an annual output value of over 500 million yuan (RMB).
The company continuously strengthens and develops its own brand, product, sales channel and other advantages, establishes an "ODM+integrated supply" model to meet the procurement needs of foreign brand merchants for medical device products, actively responds to the national "14th Five Year Plan", formulates medium and long-term enterprise development strategic goals, and, driven by national policies and market dual drivers, continuously increases its efforts to explore the domestic market, fully leveraging the industry's own advantages, Strive to achieve a win-win situation in both domestic and international markets.
The company always adheres to the core values of "people-oriented, quality first", adheres to the business purpose of "pursuing excellent quality and caring for human health", and revolves around the development concept of "sincerity, trust, and win-win cooperation", committed to providing safe and high-quality products and services. In order to develop and strengthen the medical and health industry, we look forward to more like-minded partners joining us and creating a better future together. We sincerely welcome major medical institutions and pharmaceutical units both domestically and internationally to cooperate with us and work together to build a community of human health and contribute to the global health cause.